Human Regenerative Technologies
Provider and developer of human amniotic- and placental-derived tissue allografts and preservation technologies. Operates under U.S. HCT/P regulations and holds accreditation and multiple state, federal, and Canadian registrations. Focus areas include development and processing of placental and amniotic tissue for clinical use, tissue preservation R&D, and accredited tissue bank operations.
Industries
Nr. of Employees
small (1-50)
Human Regenerative Technologies
El Segundo, California, United States, North America
Products
HydraTek Process
A proprietary technology for processing amniotic and placental tissue allografts, preserving their natural hydrated state for improved handling and delivery.
BioAware Membrane Preservation System
A system designed to maintain the structural integrity and moisture levels of membrane-based allografts, avoiding traditional methods that may compromise tissue quality.
WoundFix
A dehydrated amniotic membrane used as a wound covering for acute and chronic wounds, featuring omnidirectional application and room temperature storage.
WoundPlus
A dehydrated amniotic membrane with a natural surface, used as a wound covering for acute and chronic wounds, offering omnidirectional application and room temperature storage.
HydraTek Process
A proprietary technology for processing amniotic and placental tissue allografts, preserving their natural hydrated state for improved handling and delivery.
BioAware Membrane Preservation System
A system designed to maintain the structural integrity and moisture levels of membrane-based allografts, avoiding traditional methods that may compromise tissue quality.
WoundFix
A dehydrated amniotic membrane used as a wound covering for acute and chronic wounds, featuring omnidirectional application and room temperature storage.
WoundPlus
A dehydrated amniotic membrane with a natural surface, used as a wound covering for acute and chronic wounds, offering omnidirectional application and room temperature storage.
Services
Processing and preparation of human amniotic membrane and placental connective tissue allografts for clinical distribution, aligned with accreditation and HCT/P regulatory requirements.
Processing and preparation of human amniotic membrane and placental connective tissue allografts for clinical distribution, aligned with accreditation and HCT/P regulatory requirements.
Expertise Areas
- Tissue banking and allograft processing
- Tissue preservation and stabilization
- Regulatory compliance for HCT/Ps (21 CFR Part 1271, PHS §361)
- Wound care and orthobiologics
Key Technologies
- Allograft processing methods for amniotic and placental tissues
- Tissue preservation technologies for placental-derived materials
- Tissue banking and distribution systems
- Regulatory-compliant HCT/P handling and documentation
News & Updates
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American College of Foot & Ankle Surgeons meeting.
Participation in the Symposium on Advanced Wound Care.
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American Academy of Orthopaedic Surgeons annual meeting (exhibit and meeting dates listed).
Participation in the American College of Foot & Ankle Surgeons meeting.
Participation in the Symposium on Advanced Wound Care.